IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,531,044 | -40.5% | 239,600 | +77.6% | 0.22% | +317.0% |
| Q4 2021 | $2,575,000 | -53.8% | 134,900 | -40.3% | 0.05% | -68.6% |
| Q3 2021 | $5,574,000 | +167.7% | 226,000 | +182.5% | 0.17% | +128.4% |
| Q2 2021 | $2,082,000 | +31.5% | 80,000 | +60.0% | 0.07% | +85.0% |
| Q1 2021 | $1,583,000 | -86.5% | 50,000 | -80.2% | 0.04% | -82.1% |
| Q4 2020 | $11,739,000 | +17.7% | 253,000 | -16.5% | 0.22% | -39.6% |
| Q3 2020 | $9,975,000 | +372.5% | 303,000 | +294.0% | 0.37% | +152.7% |
| Q2 2020 | $2,111,000 | +1307.3% | 76,900 | +1438.0% | 0.15% | +630.0% |
| Q1 2020 | $150,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |